In 1993 Dr Zelig Eshhar and colleagues at the Weizmann Institute in Israel engineer the first-generation CAR molecule. Dr Eshhar had spent time in the United States in 1990 with Dr Steven Rosenberg, surgeon and cancer researcher, where they worked together to design CARs targeted at human melanoma.
